Stanford University
Showing 5,801-5,900 of 37,047 Results
-
David Chu
Veterinarian, Comparative Medicine - Veterinary Service Center
Current Role at StanfordOversee day to day operations in rodent and aquatic animal health programs including clinical medicine, health surveillance, import / export affairs, and strategic planning spreading across over a dozen facilities on and off campus. Supervise personnel engaged in rodent health surveillance enterprise. Administer veterinary care to animals in AAALAC-accredited Stanford research colonies. Participate in clinical and didactic training of residents (ACLAM sanctioned), externs, and visiting veterinary students. Provide assessments of animals prior to intrastate, interstate, and international shipments, including physical examination, review of colony history, and pertinent diagnostic tests. Review animal care and use proposals for the IACUC and coordinate the monitoring of approved research projects.
-
Derek Chu, MD
Clinical Associate Professor, Dermatology
Clinical Associate Professor (By courtesy), PediatricsBioDerek Chu, M.D., is Clinical Associate Professor of Dermatology and Pediatrics at Lucile Packard Children's Hospital. He completed his medical school and residency training at the University of Pennsylvania, followed by a pediatric dermatology fellowship at UCSF. Dr. Chu's clinical interests encompass a wide array of topics within pediatric dermatology, including vascular tumors and malformations, inflammatory skin diseases, dermato-oncology, neonatal dermatology, and procedural dermatology.
Email: derekchu@stanford.edu -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Isabella Chu
Temp - Non-Exempt, Center for Population Health Sciences
BioI have been with the Stanford School of Medicine since 2001. I received my MPH in Public Health from UC Berkeley in 2011 and joined The Stanford Center for Population Health Sciences (PHS) in 2016. My research interests focus on social and environmental determinants of health, particularly how the built environment, especially housing and transportation policy, promotes equitable access to the economy, education and other opportunities and can improve public health.
Road deaths have been the leading cause of child and young adult traumatic injury and death in the United States for many years and I want to better understand how better transportation policy can lead to safer streets for people on foot, bicycles and in automobiles.
I am the Associate Director of the Data Core at PHS. The PHS Data Core specializes in hosting large, rich, high risk data which are used by hundreds of researchers to answer questions in precision and population health. My primary responsibilities include overseeing governance and regulatory matters, data security, privacy and ethics and collaboration with the team of research scientists and engineers who have built the PHS Data Core platform. This platform and model have been replicated in several research universities throughout the United States.
Prior to joining PHS I initiated the Stanford Research Registry (SRR) which grew to over 4,000 members within two years and greatly facilitated research participation for both individuals with chronic disease as well as healthy controls in clinical trials and qualitative research. The SRR served as the foundation for the Patient Engagement Portal initiative which allows for bi-directional communication with the entire Stanford patient population and the general public for the purposes of recruitment for research, reporting research findings and allowing research participants to better understand the impacts of their service on the advancement of science. -
Jen-Fei Chu
Graduate, Stanford Center for Professional Development
BioDr. Chu is an experienced postdoctoral researcher who has built a strong track record at Academia Sinica, Taiwan. He completed his Ph.D. in Biophysics and Physical Chemistry at the Institute of Atomic and Molecular Sciences (IAMS), gaining expertise in single-molecule imaging, molecular mechanisms, and data analysis. He then applied these imaging skills to neuroscience research at the Institute of Molecular Biology (IMB), with a focus on autism spectrum disorder (ASD) and amyotrophic lateral sclerosis (ALS).
Beyond his rigorous research, Dr. Chu studied law at National Taiwan University (NTU) in preparation for the bar examination. He is now taking credit-bearing graduate courses in electrical engineering and AI at Stanford University through the Center for Global and Online Education (CGOE), working toward the advanced degrees. -
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.
For a full description of my educational informatics work, please see my website aim.stanford.edu.
My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.
I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.
The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain. -
Steven Chu
William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering
Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioAlex Weihan Chu, M.D. serves as a Clinical Assistant Professor at Stanford School of Medicine and is the Associate Chief Medical Officer and Vice President of Quality, Health Equity, and Clinical Affairs at Stanford Health Care Tri-Valley.
Dr. Chu has been a dedicated member of SHC Tri-Valley since 2015, joining as a Hospital Medicine physician after completing his residency at Stanford Hospital. He is board-certified in Internal Medicine and Clinical Informatics. Since 2016, he has served as the Medical Informatics Director, a role he continues to oversee, ensuring that technology enhances clinical workflows and patient care.
Dr. Chu has held multiple leadership roles, including serving on the Medical Executive Committee and as Vice Chief of Medicine. He previously served as Associate Chief Medical Officer for Patient Safety, Infection Control & Accreditation, Regulatory & Licensing, where he played a key role in supporting Joint Commission surveys, ensuring CDPH compliance, and leading hospital safety initiatives to address regulatory findings.
In 2024, Dr. Chu transitioned to his current role, the Associate Chief Medical Officer and Vice President for Quality, Health Equity, and Clinical Affairs where he is responsible for coordinating a comprehensive system of quality monitoring and improvement to achieve excellent patient care. He works closely with Kathleen Carrothers, Senior Director of Quality Management and Performance Improvement, to oversee clinical outcomes, data management, and performance improvement initiatives. He also leads health equity efforts and manages physician agreements, ensuring sustained high-quality care and strategic physician engagement.
Dr. Chu brings expertise in physician engagement, clinical oversight, clinical informatics, and quality improvement. His experience in driving multi-disciplinary change and advancing health equity to aligns with the hospital’s mission and vision.
Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring the latest advancements in technology. -
Ian Chua
Clinical Associate Professor, Pediatrics
BioIan Chua, MD, MHPE, MBA is a bicoastal pediatric hospitalist and clinical associate professor of pediatrics at Stanford Children’s Health (Palo Alto, CA) and Children’s National Medical Center (Washington, DC). He completed his residency at Stanford Children’s with concentrations in medical education and quality improvement. He obtained his Masters’ in Health Professions Education at University of Illinois in Chicago. He currently co-directs the Quality and Leadership Training (QUILT) program in the department of pediatrics as well as the PHM Leadership Rotation. He also directs the ACGME Fellows’ Common Core Curriculum, the PHM Fellowship Medical Education Pathway, and the Pediatric residency medical education pathway at Children’s National Medical Center. His interests have been in educational scholarship and professional development of transitional learners including junior faculty. Nationally, he has been involved in shaping the national PHM fellows' conference and is the current co-chair for the AAP SOHM Emerging Leaders Conference.
-
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
-
Mei-Sze Chua
Sr Res Scientist-Basic Ls, Surgery - General Surgery
Current Role at StanfordI spearhead multiple projects stemming from the lab’s initial genomics study on liver cancer, with the goal of translating gene expression data of liver cancer patients into improved clinical approaches for the diagnosis and therapy of this fatal disease. I have successfully led inter-disciplinary projects, mentored postdoctoral fellows and visiting scientists, and effectively worked with diverse groups of collaborators from academic and industrial settings. I am committed to help eliminate global health care burden associated with hepatitis B and liver cancer.
-
Cynthia Chuang
Clinical Professor, Radiation Oncology - Radiation Physics
BioEducation:
1990-B.S., Bioelectrical Engineering (6-1B), Massachusetts Institute of Technology, Cambridge, MA
1992-M.S., Bioengineering, University of Pennsylvania, Philadelphia, PA
1994-M.S., Nuclear Engineering (NMR Spectroscopy), Massachusetts Institute of Technology, Cambridge, MA
1999-Ph.D., Nuclear Engineering (Boron Neutron Capture Therapy), Massachusetts Institute of Technology, Cambridge, MA
2001-Postdoctoral Fellowship (Peregrine Project), Lawrence Livermore National Laboratory
2003-Medical Physics Residency, University of California, San Francisco (joint 3.5-year postdoctoral and residency program)
Academic Appointments:
2003 - 2005-Clinical Instructor, Radiation Oncology, University of California, San Francisco, San Francisco, California
2005 - 2009-Assistant Adjunct Professor, Radiation Oncology, University of California, San Francisco, San Francisco, California
2009 - 2013-Assistant Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California
2013 - 2017-Associate Professor In Residence, Radiation Oncology, University of California, San Francisco, San Francisco, California
2017 - 2018-Associate Professor of Clinical Radiation Oncology, University of California, San Francisco, San Francisco, California
2019 - 2023-Clinical Associate Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA
2023- Present-Clinical Professor, Department of Radiation Oncology, Clinical Educator Line, Stanford University, Stanford, CA -
Henry Chubb
Clinical Associate Professor, Pediatrics - Cardiology
Current Research and Scholarly Interestshttps://www.researchgate.net/profile/Henry_Chubb
-
William Chueh
Director, Precourt Institute for Energy, Kimmelman Professor, Professor of Materials Science and Engineering, of Energy Science and Engineering, of Photon Science and Senior Fellow at the Precourt Institute for Energy
BioThe availability of low-cost but intermittent renewable electricity (e.g., derived from solar and wind) underscores the grand challenge to store and dispatch energy so that it is available when and where it is needed. Redox-active materials promise the efficient transformation between electrical, chemical, and thermal energy, and are at the heart of carbon-neutral energy cycles. Understanding design rules that govern materials chemistry and architecture holds the key towards rationally optimizing technologies such as batteries, fuel cells, electrolyzers, and novel thermodynamic cycles. Electrochemical and chemical reactions involved in these technologies span diverse length and time scales, ranging from Ångströms to meters and from picoseconds to years. As such, establishing a unified, predictive framework has been a major challenge. The central question unifying our research is: “can we understand and engineer redox reactions at the levels of electrons, ions, molecules, particles and devices using a bottom-up approach?” Our approach integrates novel synthesis, fabrication, characterization, modeling and analytics to understand molecular pathways and interfacial structure, and to bridge fundamentals to energy storage and conversion technologies by establishing new design rules.
-
Hayson Chui
Affiliate, IT Services
BioHayson Chui, PA-C is an APP fellow at Stanford Health Care training in the field of cardiothoracic surgery. He graduated with his B.S. in Psychobiology from the University of California, Los Angeles in 2020 and his Master of Science in Physician Assistant (PA) Studies from Southern California University of Health Sciences in 2024. His area of clinical practice is in cardiothoracic surgery, primarily specializing in surgical interventions for cardiac and pulmonary disorders.
-
Jonathan Wayne Chun
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
Current Role at StanfordInpatient Rotation Director for the VA
-
Vivek Chundru
Ph.D. Student in Bioengineering, admitted Autumn 2025
Current Research and Scholarly InterestsMotor control, brain-computer interface, computational neuroscience
-
Benjamin I. Chung
Professor of Urology and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsRenal cell carcinoma and prostate cancer outcomes research and epidemiology.
-
Lorinda Chung
Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology
On Leave from 05/26/2026 To 06/24/2026Current Research and Scholarly InterestsMy research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.
-
Philip Chung
Instructor, Anesthesiology, Perioperative and Pain Medicine
BioPhilip Chung is a physician-scientist, general anesthesiologist, and healthcare AI researcher at Stanford University School of Medicine. He develops and evaluates AI systems that leverage electronic health records to support perioperative decision-making and patient safety. His research interests include large language models, healthcare foundation models, clinical AI evaluation, perioperative outcomes research, and the safe translation of AI technologies into real-world clinical practice. His work has been published in leading journals including NEJM AI, JAMA Surgery, Nature Medicine, and The Lancet Digital Health. In addition to his clinical practice at Stanford Hospital, he is also a member of Nima Aghaeepour’s laboratory.
